Technical Analysis for ATRA - Atara Biotherapeutics, Inc.

Grade Last Price % Change Price Change
grade D 37.25 2.11% 0.77
ATRA closed up 2.11 percent on Friday, January 18, 2019, on 44 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ATRA trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 50 DMA Bullish 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 50 DMA Resistance Bearish 2.11%
Jan 17 Stochastic Sell Signal Bearish 2.11%
Jan 17 Weak + Overbought Other 2.11%
Jan 17 Overbought Stochastic Strength 2.11%
Jan 16 50 DMA Resistance Bearish 3.44%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.44%
Jan 16 Weak + Overbought Other 3.44%
Jan 16 Overbought Stochastic Strength 3.44%

Older signals for ATRA ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Atara Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of muscle wasting conditions and oncology. Its lead product candidate is PINTA 745, which is in a Phase II clinical trial for the treatment of protein-energy wasting in end-stage renal disease patients. The company is also developing STM 434, a targeted therapy for ovarian cancer and other solid tumors; and a pipeline of product candidates that are in preclinical development. Atara Biotherapeutics, Inc. was founded in 2012 and is headquartered in Brisbane, California.
Is ATRA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 54.45
52 Week Low 27.85
Average Volume 611,903
200-Day Moving Average 39.4436
50-Day Moving Average 36.755
20-Day Moving Average 33.901
10-Day Moving Average 35.128
Average True Range 2.4522
ADX 15.98
+DI 23.1559
-DI 22.1894
Chandelier Exit (Long, 3 ATRs ) 33.5434
Chandelier Exit (Short, 3 ATRs ) 35.2066
Upper Bollinger Band 38.3685
Lower Bollinger Band 29.4335
Percent B (%b) 0.87
BandWidth 26.356155
MACD Line -0.2087
MACD Signal Line -0.788
MACD Histogram 0.5792
Fundamentals Value
Market Cap 1.14 Billion
Num Shares 30.6 Million
EPS -3.33
Price-to-Earnings (P/E) Ratio -11.19
Price-to-Sales 0.00
Price-to-Book 1.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.55
Resistance 3 (R3) 39.33 38.35 39.16
Resistance 2 (R2) 38.35 37.77 38.46 39.03
Resistance 1 (R1) 37.80 37.40 38.08 38.02 38.91
Pivot Point 36.82 36.82 36.96 36.93 36.82
Support 1 (S1) 36.27 36.24 36.55 36.49 35.59
Support 2 (S2) 35.29 35.87 35.40 35.47
Support 3 (S3) 34.74 35.29 35.34
Support 4 (S4) 34.96